Knoll Capital Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001325083

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltBuy & Hold how tags are computed

Q2 2026 · 37 positions · Total reported value $214.31M · Top-10 concentration 62.0% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 5.3% · 1 new · 0 cut · 1 exited

Active Share (vs S&P 500): 99.5% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +4.8% · vs SPY -10.0% · Prev Value $180.17M — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2026 13F filing, Knoll Capital Management, LLC disclosed 37 equity positions with a combined reported value of $214.31M. The filing implies a focused portfolio: its ten largest positions account for 62.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / Buy & Hold.

The largest disclosed positions as of Q2 2026 were BHVN ($35.01M), MGTX ($16.89M), PHYS ($11.68M). By sector, the heaviest allocations are Health Care 50.9%, Materials 27.3%. Versus the prior quarter, allocation shifted toward Health Care (+12.6pp), Consumer Discretionary (+2.1pp) and away from Other (-1.1pp), Financials (-2.2pp).

Versus the prior quarter, Knoll Capital Management, LLC opened 1 new positions, trimmed 0 and fully exited 1, a turnover rate of 5.3% of positions. The portfolio's overlap with the prior quarter was 95% of names.

The largest new positions opened in Q2 2026 were ABVX ($4.66M).

Of the 1 positions fully exited versus the prior quarter, the largest were CRDL ($135.00K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • ABVX ABIVAX SA · $4.66M

Fully Exited (vs previous quarter)

  • CRDL CARDIOL THERAPEUTICS INC · prev qtr: $135.00K

Insider Transactions (Form 4)

Latest Knoll Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Knoll Capital Management, LLC is an SEC-registered 13F filer. As of Q2 2026 it reported 37 US equity positions with a combined value of $214.31M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 37 positions · $214.31M reported value (Q2 2026)
  • Top 10 holdings = 62.0% of reported value
  • Largest position: BHVN (BIOHAVEN LTD) at 16.3%
  • Average position size: $5.79M

Sector Tilt

  • Health Care 50.9%
  • Materials 27.3%
  • Industrials 10.5%
  • (classified holdings cover 97% of value)

Quarterly Activity

  • Q2 2026: 1 new, 5 added, 1 exited
  • 31 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The fund's rebalancing appears to be focused on maintaining a diversified healthcare sector presence while cautiously holding onto other sectors like Financials and Materials. There is a slight increase in healthcare investments, suggesting a bullish view on the health care sector. 2. Key Moves: - Added: BIOHAVEN LTD (BHVN), OCULAR THERAPEUTIX INC (OCUL), NUVATION BIO INC (NUVB). Added shares in OCUL by 91.6%. - Reduced: None notable. - Held: Most of the positions were held steady, with no significant changes in share count or weight. 3. Portfolio Structure: - Passive/Active: The rebalancing appears to be more passive, with a focus on maintaining existing positions rather than actively shifting funds. - Sector Bias: The portfolio has a strong bias towards healthcare, with 37.5% of the total value allocated to the sector. It also has a presence in Financials and Materials. - Risk Appetite: The risk appetite seems moderate, as there are no significant changes in the portfolio, and the healthcare sector is known for its volatility. 4. Per-Holding One-Liner: - BHVN: Health care company focusing on drug discovery and development. - MGTX: Biopharmaceutical company focusing on therapies for ophthalmic diseases. - PHYS: Asset management company. - ALDX: Biotechnology company focusing on therapies for allergic and inflammatory diseases. - OCUL: Biotechnology company specializing in ophthalmic therapies. - RGLD: Gold mining company. - ENTX: Biopharmaceutical company focusing on treatments for rare diseases. - NUVB: Biotechnology company focusing on therapies for cancer and other diseases. - AEM: Mining company focused on gold and silver. - SA: Mining company focused on gold. 5. One-Sentence Style Summary: Knoll Capital Management maintained a conservative, diversified approach in Q2 2026, increasing its healthcare exposure while holding steady in other sectors, reflecting a cautious optimism towards the health care industry.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 50.9%
Materials 27.3%
Industrials 10.5%
Financials 5.4%
Other 3.2%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 2.35M $35.01M 16.33%
16.33%
Add
2 1.25M $16.89M 7.88%
7.88%
Hold
3 387.06K $11.68M 5.45%
5.45%
Hold
4 5.48M $11.66M 5.44%
5.44%
Hold
5 1.15M $11.30M 5.27%
5.27%
Add
6 52.75K $10.53M 4.91%
4.91%
Hold
7 5.88M $10.41M 4.86%
4.86%
Hold
8 1.60M $9.08M 4.24%
4.24%
Add
9 52.75K $8.18M 3.82%
3.82%
Hold
10 317.00K $8.16M 3.81%
3.81%
Hold
11 320.00K $7.56M 3.53%
3.53%
Hold
12 225.00K $7.12M 3.32%
3.32%
Hold
13 245.00K $6.93M 3.23%
3.23%
Hold
14 32.00K $6.67M 3.11%
3.11%
Hold
15 359.00K $5.69M 2.66%
2.66%
Hold
16 13.00K $5.69M 2.66%
2.66%
Hold
17 1.21M $4.74M 2.21%
2.21%
Add
18 35.00K $4.66M 2.18%
2.18%
New
19 100.03K $4.48M 2.09%
2.09%
Hold
20 222.16K $4.19M 1.96%
1.96%
Hold
21 115.00K $3.45M 1.61%
1.61%
Hold
22 485.51K $3.00M 1.40%
1.40%
Hold
23 1.00M $2.76M 1.29%
1.29%
Hold
24 485.00K $1.95M 0.91%
0.91%
Hold
25 7.65K $1.85M 0.86%
0.86%
Hold
26 10.00K $1.81M 0.84%
0.84%
Hold
27 96.13K $1.57M 0.73%
0.73%
Hold
28 50.00K $1.52M 0.71%
0.71%
Hold
29 12.50K $1.40M 0.66%
0.66%
Hold
30 2.17K $1.10M 0.52%
0.52%
Hold
31 50.00K $873.00K 0.41%
0.41%
Hold
32 66.62K $820.67K 0.38%
0.38%
Hold
33 122.92K $523.64K 0.24%
0.24%
Hold
34 9.18K $489.03K 0.23%
0.23%
Hold
35 160.00K $486.40K 0.23%
0.23%
Hold
36 4.09K $56.82K 0.03%
0.03%
Add
37 50.62K $20.82K 0.01%
0.01%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q2)

P 70% R 70% F1 70% (modelled on 2026-Q1; 7/10 hit)

Low-confidence forecast This fund replaces about 26% of its Top-10 each quarter and backtests at F1 74% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (10 quarters)

Avg precision 74% · recall 74% · F1 74% · avg rank error 2.2 · Top-10 turnover 26%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 50% 50% 50% ALDX · BHVN · APLT · AVDL · SIL · HOOK · VRNA · AEM · SILV · WPM APLT · BHVN · ALDX · AVDL · GLD · ENTX · ALT · HOOK · SA · EQX
2024-Q2 80% 80% 80% APLT · BHVN · ALDX · AVDL · ENTX · GLD · ALT · HOOK · SA · AEM APLT · BHVN · ALDX · AVDL · ALT · ENTX · GLD · SILV · KGC · AEM
2024-Q3 70% 70% 70% APLT · BHVN · ALDX · ALT · AVDL · ENTX · GLD · SILV · KGC · AEM APLT · BHVN · ALDX · AGI · AVDL · GLD · ENTX · HOOK · ALT · VRNA
2024-Q4 80% 80% 80% APLT · BHVN · ALDX · AGI · AVDL · GLD · ALT · ENTX · HOOK · OCUL BHVN · ALDX · ENTX · VRNA · ALT · GLD · MGTX · AVDL · OCUL · APLT
2025-Q1 70% 70% 70% BHVN · ALDX · ENTX · VRNA · ALT · GLD · MGTX · AVDL · OCUL · APLT ALDX · BHVN · ENTX · GLD · MGTX · AEM · ALT · KGC · SAND · AVDL
2025-Q2 90% 90% 90% ALDX · BHVN · ENTX · GLD · MGTX · AEM · KGC · ALT · SAND · AVDL ALDX · BHVN · ENTX · GLD · MGTX · KGC · AEM · SAND · AVDL · ELTX
2025-Q3 90% 90% 90% ALDX · BHVN · ENTX · GLD · MGTX · KGC · AEM · SAND · AVDL · ELTX ALDX · BHVN · GLD · ENTX · MGTX · KGC · AVDL · AEM · SAND · SA
2025-Q4 80% 80% 80% ALDX · BHVN · GLD · ENTX · KGC · MGTX · AVDL · AEM · SAND · SA ALDX · BHVN · NUVB · AVDL · GLD · RGLD · KGC · ENTX · MGTX · SA
2026-Q1 60% 60% 60% BHVN · ALDX · NUVB · RGLD · AVDL · GLD · KGC · ENTX · MGTX · SA BHVN · PHYS · RGLD · MGTX · AEM · KGC · ALDX · SA · FNV · SSRM
2026-Q2 ★ 70% 70% 70% BHVN · RGLD · PHYS · AEM · MGTX · KGC · ALDX · SA · FNV · SSRM BHVN · MGTX · PHYS · ALDX · OCUL · RGLD · ENTX · NUVB · AEM · SA

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

FAQ

What did Knoll Capital Management, LLC buy in 2026-Q2?

In its 2026-Q2 13F filing, Knoll Capital Management, LLC reported 37 equity positions worth $214.31M in aggregate; its largest disclosed positions were BHVN ($35.01M), MGTX ($16.89M), PHYS ($11.68M).

How large is Knoll Capital Management, LLC's portfolio?

Knoll Capital Management, LLC reported $214.31M of long equity holdings across 37 positions as of 2026-Q2. Top-10 holdings account for 62.0% of reported value.

What is Knoll Capital Management, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / Buy & Hold, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/knoll-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →